Literature DB >> 21704057

Assessment of linear-scale indices for perimetry in terms of progression in early glaucoma.

Stuart K Gardiner1, Shaban Demirel, Chris A Johnson, William H Swanson.   

Abstract

Currently, global indices that summarize the visual field combine sensitivities on a logarithmic (decibel) scale. Recent structure-function models for glaucoma suggest that contrast sensitivity should be converted to a linear scale before averaging across visual field locations, to better relate sensitivity with the number of surviving retinal ganglion cells (RGCs). New indices designed to represent the number of RGCs already lost are described. At least one was found to be a significantly better predictor of subsequent rate of change than traditional Mean Deviation (p=0.014) in participants with glaucomatous optic neuropathy. Issues concerning the creation of optimal global indices are discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21704057      PMCID: PMC3152648          DOI: 10.1016/j.visres.2011.06.009

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  45 in total

Review 1.  Correlation of visual function with optic nerve and nerve fiber layer structure in glaucoma.

Authors:  J Caprioli
Journal:  Surv Ophthalmol       Date:  1989-02       Impact factor: 6.048

2.  Ganglion cell loss and dysfunction: relationship to perimetric sensitivity.

Authors:  Neville Drasdo; Katharine E Mortlock; Rachel V North
Journal:  Optom Vis Sci       Date:  2008-11       Impact factor: 1.973

3.  A new generation of algorithms for computerized threshold perimetry, SITA.

Authors:  B Bengtsson; J Olsson; A Heijl; H Rootzén
Journal:  Acta Ophthalmol Scand       Date:  1997-08

4.  Variation of nerve fibre layer thickness measurements with age and ethnicity by scanning laser polarimetry.

Authors:  D Poinoosawmy; L Fontana; J X Wu; F W Fitzke; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

5.  Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

Authors:  Michael A Kass; Mae O Gordon; Feng Gao; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John K Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson
Journal:  Arch Ophthalmol       Date:  2010-03

6.  Psychophysical investigation of ganglion cell loss in early glaucoma.

Authors:  Paul G D Spry; Chris A Johnson; Steven L Mansberger; George A Cioffi
Journal:  J Glaucoma       Date:  2005-02       Impact factor: 2.503

7.  Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2.

Authors:  A C Viswanathan; F W Fitzke; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

8.  A test of a linear model of glaucomatous structure-function loss reveals sources of variability in retinal nerve fiber and visual field measurements.

Authors:  Donald C Hood; Susan C Anderson; Michael Wall; Ali S Raza; Randy H Kardon
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

9.  Structure-function relationship depends on glaucoma severity.

Authors:  M Gonzalez-Hernandez; L E Pablo; K Armas-Dominguez; R Rodriguez de la Vega; A Ferreras; M Gonzalez de la Rosa
Journal:  Br J Ophthalmol       Date:  2009-06-02       Impact factor: 4.638

10.  Development and evaluation of a contrast sensitivity perimetry test for patients with glaucoma.

Authors:  Aliya Hot; Mitchell W Dul; William H Swanson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-31       Impact factor: 4.799

View more
  9 in total

1.  Correlating perimetric indices with three nerve fiber layer thickness measures.

Authors:  Deborah Goren; Shaban Demirel; Brad Fortune; Stuart K Gardiner
Journal:  Optom Vis Sci       Date:  2013-12       Impact factor: 1.973

2.  Measuring Rates of Visual Field Progression in Linear Versus Nonlinear Scales: Implications for Understanding the Relationship Between Baseline Damage and Target Rates of Glaucoma Progression.

Authors:  Kevin Liebmann; Carlos Gustavo De Moraes; Jeffrey M Liebmann
Journal:  J Glaucoma       Date:  2017-08       Impact factor: 2.503

3.  Improved estimates of visual field progression using bayesian linear regression to integrate structural information in patients with ocular hypertension.

Authors:  Richard A Russell; Rizwan Malik; Balwantray C Chauhan; David P Crabb; David F Garway-Heath
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-14       Impact factor: 4.799

4.  Characterizing Visual Fields in RPGR Related Retinitis Pigmentosa Using Octopus Static-Automated Perimetry.

Authors:  Thomas M W Buckley; Amandeep Singh Josan; Laura J Taylor; Jasleen K Jolly; Jasmina Cehajic-Kapetanovic; Robert E MacLaren
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

5.  A method to estimate the amount of neuroretinal rim tissue in glaucoma: comparison with current methods for measuring rim area.

Authors:  Stuart K Gardiner; Ruojin Ren; Hongli Yang; Brad Fortune; Claude F Burgoyne; Shaban Demirel
Journal:  Am J Ophthalmol       Date:  2013-11-13       Impact factor: 5.258

6.  Evaluation of the Structure-Function Relationship in Glaucoma Using a Novel Method for Estimating the Number of Retinal Ganglion Cells in the Human Retina.

Authors:  Ali S Raza; Donald C Hood
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

7.  Assessing assumptions of a combined structure-function index.

Authors:  William H Swanson; Douglas G Horner
Journal:  Ophthalmic Physiol Opt       Date:  2015-01-21       Impact factor: 3.117

8.  Using perimetric data to estimate ganglion cell loss for detecting progression of glaucoma: a comparison of models.

Authors:  Derek A Price; William H Swanson; Douglas G Horner
Journal:  Ophthalmic Physiol Opt       Date:  2017-04-25       Impact factor: 3.117

9.  Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma.

Authors:  Jessica Tang; Flora Hui; Xavier Hadoux; Bernardo Soares; Michael Jamieson; Peter van Wijngaarden; Michael Coote; Jonathan G Crowston
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.